646 results on '"Baylink, D. J."'
Search Results
2. Prospektive Untersuchung der Osteoporose-prophylaktischen Wirkung von Ossein-Mineral-Komplex bei Patientinnen mit artefizieller Postmenopause
3. Detecting Novel Bone Density and Bone Size Quantitative Trait Loci Using a Cross of MRL/MpJ and CAST/EiJ Inbred Mice
4. Disruption of Four-and-a-Half LIM 2 Decreases Bone Mineral Content and Bone Mineral Density in Femur and Tibia Bones of Female Mice
5. High Osteoblastic Activity In C3H/HeJ Mice Compared to C57BL/6J Mice Is Associated with Low Apoptosis in C3H/HeJ Osteoblasts
6. Serum Levels of Insulin-Like Growth Factor (IGF); IGF-Binding Proteins-3, -4, and -5; and Their Relationships to Bone Mineral Density and the Risk of Vertebral Fractures in Postmenopausal Women
7. Development and Application of a Synthetic Peptide-Based Osteocalcin Assay for the Measurement of Bone Formation in Mouse Serum
8. Development and Application of a Serum C-Telopeptide and Osteocalcin Assay to Measure Bone Turnover in an Ovariectomized Rat Model
9. Exercise and Mechanical Loading Increase Periosteal Bone Formation and Whole Bone Strength in C57BL/6J Mice but Not in C3H/Hej Mice
10. Vitamin D Therapy of Osteoporosis: Plain Vitamin D Therapy Versus Active Vitamin D Analog (D-Hormone) Therapy
11. Differential Effects of Two Protein Tyrosine Kinase Inhibitors, Tyrphostin and Genistein, on Human Bone Cell Proliferation as Compared with Differentiation
12. Osteogenic Protein-1 Stimulates mRNA Levels of BMP-6 and Decreases mRNA Levels of BMP-2 and -4 in Human Osteosarcoma Cells
13. Rationale for active vitamin D analog therapy in senile osteoporosis
14. Serum fluoride and serum osteocalcin levels in response to a novel sustained-release monofluorophosphate preparation: Comparison with plain monofluorophosphate
15. The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued
16. Dexamethasone enhances the osteogenic effects of fluoride in human TE85 osteosarcoma cellsin vitro
17. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone
18. Phenytoin and fluoride act in concert to stimulate bone formation and to increase bone volume in adult male rats
19. On fluoride and bone strength
20. Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects
21. Low dose phenytoin is an osteogenic agent in the rat
22. Combined magnetic fields increased net calcium flux in bone cells
23. The effects of the insulin-like growth factors and transforming growth factor β on the jun proto-oncogene family in MC3T3-E1 cells
24. Development of a heterologous radioimmunoassay for canine osteocalcin
25. Spinal fractures during fluoride therapy for osteoporosis: Relationship to spinal bone density
26. Incorporation of sodium fluoride into cortical bone does not impair the mechanical properties of the appendicular skeleton in rats
27. Fluoride therapy for osteoporosis: A review of dose response, duration of treatment, and skeletal sites of action
28. The diagnosis and management of osteoporosis
29. Recombinant Human Insulin-Like Growth Factor-Binding Protein-5 Stimulates Bone Formation Parameters in Vitro and in Vivo*
30. Predictions on future diagnosis and treatment of osteoporosis: Results and discussion of a recent opinion poll
31. Changes in markers of bone formation and resorption in a bed rest model of weightlessness
32. Further Evidence Supporting the Phosphate Leak Hypothesis of Idiopathic Hypercalciuria
33. Glucocorticoid-Induced Osteoporosis
34. Concomitant phenytoin therapy doubles the osteogenic and densitometric effect of fluoride therapy in osteoporosis
35. Rationale for active vitamin D analogue therapy in osteoporosis
36. Serum fluoride and bone formation parameters in response to a novel sustained release monofluorophosphate (MEP-SR), comparison with plain MFP
37. Increased bone microhardness in fluoride treated rats
38. 24,25(OH)2D3, bone formation, and bone resorption in vitamin D-deficient, azotemic rats
39. Bone mineralization and metabolism of3H-25-hydroxyvitamin D3 in thyroparathyroidectomized rats treated with parathyroid extract
40. An improved technique for rapid autoradiography of cells and tissue sections
41. In vitro evidence that local and systemic skeletal effectors can regulate3[H]-thymidine incorporation in chick calvarial cell cultures and modulate the stimulatory actions(s) of embryonic chick bone extract
42. Effects of Vitamin D and its Metabolites on Bone
43. An Histologic Comparison of l,25(OH)2 Vitamin D Treatment with Calcium Supplementation in Renal Osteodystrophy
44. In Vitro Regulation of 25-Hydroxyvitamin D3 Metabolism by Avian Kidney Cells in Serum-Free Medium
45. Further Evidence Supporting the Phosphate Leak Hypothesis of Idiopathic Hypercalciuria
46. Clincal Efficacy of 1,25-Dihydroxy-Vitamin D3 in Renal Osteodystrophy
47. The causes of bone scintigram hot spots in fluoride-treated osteoporotic patients
48. Fluoride pharmacokinetics in good and poor responders to fluoride therapy
49. Basic science and clinical utility of biochemical markers of bone turnover — A congress report*
50. Evidence for arrested bone formation during spaceflight
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.